Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
A projected 93 million U.S. adults who are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy, a University of California, Irvine study has found. The researchers projected this based on the known weight loss effects (15% average weight loss) of …
Researchers and scientists at the University of Kentucky’s Sander-Brown Center on Aging have been investigating the idea that various anti-inflammatory drugs might be effective treatments for Alzheimer’s Disease (AD), this work has been focused on protein p38 as a potential target drug to treat AD and other conditions with neuroinflammatory dysfunction. Findings from their recent …
Article courtesy of Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world’s top cardiologists, a best-selling author, lecturer, and a leading expert in plant-based nutrition and holistic care. Atrial fibrillation (AF) is a heart rhythm disorder that is linked to an increased …
According to a study conducted by researchers from the University of Colorado Anschutz Medical Campus published in the journal PLOS One, the use and discontinuation of benzodiazepines are associated with nervous system injury and negative life effects that persist even after discontinued use. Millions of people have been taking benzos like Valium, Xanax, and Klonopin …
As people age, the need for medications to treat various health issues increases significantly. However, medication safety and effectiveness are of utmost importance for seniors in particular. The role of primary care physicians is crucial in ensuring that older individuals receive safe and effective treatment. This article explores the importance of medication use in seniors …
Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily injections to avoid peripheral diseases caused by extremes of high or low blood sugar. Automated insulin delivery systems, also called artificial pancreases, make diabetes management …
Research Highlights: Aβ in aqueous brain extracts (oligomers, protofibrils) are insoluble, and fibrillar The diffusible Aβ fibrils have the same atomic structure as amyloid plaque fibrils Lecanemab binds to and protects against the synaptotoxicity of diffusible fibrils For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated …
Image Caption: T cells are a type of white blood cell that play a central role in the immune response. Photo credit: NIAID. When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that. Scientists at the University …
Image Caption: Northwestern Medicine scientists led by Adam Sonabend report results of the first-in-human clinical trial using a skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate large, critical regions of the human brain to deliver chemotherapy. Image Credit: Northwestern University News Release Highlights: The first-in-human trial used a novel ultrasound device to …
The drug, called Mounjaro, was approved for type-2 diabetes earlier last year and is currently under review for use in the treatment of obesity and being overweight. Experts are anticipating approval from the agency by 2024. Once approved, Mounjaro becomes the latest in a slew of newly FDA-greenlit weight loss medications that aim to address …